CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Farmaexplorer.it
Xagena Salute

Search results for "PCI"

For patients with two or more diseased coronary arteries, CABG is associated with higher adjusted rates of long-term survival than stenting. Researchers compared outcomes for coronary-artery bypass ...


A study showed that patients who arrive at a hospital during off-hours and on the weekend following a heart attack have longer times to the restoration of normal blood flow and a higher risk of death. ...


In the most up-to-date analysis yet of this contentious issue, researchers from the University of Michigan Cardiovascular Center and the Blue Cross Blue Shield of Michigan Cardiovascular Consortium fi ...


Aspirin and Clopidogrel ( Plavix ) are platelet antiaggregant drugs widely used and proven to be effective in the treatment of an acute coronary syndrome ( ACS ). High-risk patients with non-ST segme ...


Preliminary results from the ASSENT-4 PCI ( Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction-4 Percutaneous Coronary Intervention ) study showed that m ...


Results from three early-phase, cross-over studies demonstrated that all subjects responded to Prasugrel ( Effient ), an investigational antiplatelet agent, while 22 to 43 percent of the same subjects ...


The European Society of Cardiology ( ESC ) has published in the European Heart Journal a policy statement on reperfusion therapy in ST-segment elevation myocardial infarction ( STEMI ). According ...


A study, published in the Journal of the American College of Cardiology, has shown when life-threatening problems occur during angioplasty procedures, doctors may perform emergency coronary artery by ...


The role of intracoronary infusion of autologous bone marrow cells in the management of acute myocardial infarction was examined in the ASTAMI trial. The ASTAMI investigators limited enrollment to ...


Despite advances in therapy for acute myocardial infarction, mortality and morbidity related to post–myocardial infarction left ventricular dysfunction remain high.  To date, the clinical tools f ...


The controversial practice of blood transfusions for patients suffering from cardiac episodes may lead to an increased risk of mortality, and may be correlated to transfusion blood type and blood age, ...


Primary percutaneous coronary intervention ( PCI ) is more effective than fibrinolytic therapy for ST-segment elevation acute myocardial infarction ( STEMI ), but time to intervention can be considera ...


Therapy that involved bone marrow stem cells did not improve cardiac function in patients following a myocardial infarction. There has been increasing evidence that stem cells contribute to regenerat ...


The ACUITY ( Acute Catheterization and Urgent Intervention Triage strategy ) trial has assessed the potential of the injectable anti-clotting medicine Bivalirudin ( Angiomax ) in patients experiencing ...


Use of Pexelizumab immediately before and for 24 hours after stent placement or angioplasty for myocardial infarction patients did not have any significant treatment effect compared to placebo. Acu ...